Results 141 to 150 of about 20,136 (185)

Real-world Effectiveness of the Adjuvanted Recombinant Zoster Vaccine in ≥50-year-old Adults With Autoimmune Diseases. [PDF]

open access: yesJ Infect Dis
Constenla D   +7 more
europepmc   +1 more source

Abstract CT067: Pembrolizumab with and without sacituzumab govitecan as first-line treatment for metastatic non-small-cell lung cancer (NSCLC) with PD-L1 TPS ≥50%: phase 3 KEYNOTE-D46/EVOKE-03 study

open access: closedCancer Research, 2023
Abstract Background: Sacituzumab govitecan is an antibody-drug conjugate comprising an anti-trophoblast cell-surface antigen 2 (Trop-2) antibody coupled to a potent payload, SN-38, via a proprietary, hydrolysable linker. In heavily pretreated patients with metastatic NSCLC, sacituzumab govitecan showed a durable antitumor response and ...
Mor Moskovitz   +8 more
openaire   +2 more sources

Structural determination of the K14 capsular polysaccharide from an ST25 Acinetobacter baumannii isolate, D46

open access: closedCarbohydrate Research, 2015
The structure of the capsular polysaccharide (CPS) recovered from D46, an extensively antibiotic resistant ST25 Acinetobacter baumannii clinical isolate, was elucidated. The structure was resolved on the basis of NMR spectroscopy and chemical analyses, and was found to contain a branched neutral pentasaccharide with a backbone composed of GalpNAc and ...
Kenyon, Johanna J   +2 more
  +7 more sources

Synthesis of the Pentasaccharide of the K14 Capsular Polysaccharide of Antibiotic Resistant ST25 Acinetobacter baumannii isolate, D46 and O ‐Polysaccharide of Acinetobacter baumannii O11

open access: closedChemistrySelect
Abstract Synthesis of the pentasaccharide corresponding to the K14 capsular polysaccharide from ST25 Acinetobacter baumannii isolate, D46 and O ‐polysaccharide of Acinetobacter baumannii O11 has been achieved in very good yield using a
Abhijit Rana, Anup Kumar Misra
openaire   +2 more sources

Home - About - Disclaimer - Privacy